Free Trial

Nutrien (NYSE:NTR) Releases Quarterly Earnings Results, Misses Estimates By $0.13 EPS

Nutrien logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Nutrien reported EPS of $0.61, missing the $0.74 consensus and falling from $0.97 a year earlier; net profit declined 39% to about $290 million.
  • Quarterly revenue rose 0.9% year over year to $6.06 billion, exceeding the $5.76 billion estimate. The company declared a quarterly dividend of $0.55 per share.
  • Higher sulfur costs and weakness in phosphate contributed to the earnings shortfall, and Nutrien plans to close its Florida plant.
  • Five stocks to consider instead of Nutrien.

Nutrien (NYSE:NTR - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.74 by ($0.13), Briefing.com reports. Nutrien had a return on equity of 8.88% and a net margin of 8.44%. During the same period in the previous year, the firm earned $0.97 earnings per share. The firm's revenue for the quarter was up .9% compared to the same quarter last year.

Nutrien Stock Performance

Shares of NTR traded up $2.73 during trading hours on Wednesday, hitting $72.05. The stock had a trading volume of 3,439,787 shares, compared to its average volume of 2,338,140. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.86 and a current ratio of 1.39. The firm has a 50-day moving average price of $72.92 and a 200 day moving average price of $71.06. Nutrien has a fifty-two week low of $53.65 and a fifty-two week high of $85.36. The firm has a market capitalization of $34.24 billion, a price-to-earnings ratio of 14.81, a PEG ratio of 0.77 and a beta of 0.67.

Nutrien News Summary

Here are the key news stories impacting Nutrien this week:

  • Positive Sentiment: Revenue was $6.06 billion, topping the $5.76 billion FactSet estimate, and Nutrien declared a quarterly dividend of US$0.55 per share. Revenue report Dividend announcement
  • Neutral Sentiment: The company reported $1.31 billion in adjusted EBITDA and said it generated $4.85 billion in adjusted EBITDA over the first nine months of the year. Third-quarter results
  • Negative Sentiment: Adjusted earnings per share were $0.61, below the $0.74 consensus and down from $0.97 a year earlier. Net profit fell 39% to about $290 million, despite the revenue beat. Earnings estimate comparison Profit decline report
  • Negative Sentiment: Reports cited higher sulfur costs and a phosphate business downturn as factors behind the earnings shortfall. Nutrien also plans to close its Florida plant, adding to concerns about near-term operating pressures. Costs and Florida plant report

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on NTR. Freedom Broker started coverage on shares of Nutrien in a report on Tuesday, October 27th. They issued a "hold" rating and a $78.00 price target on the stock. Canadian Imperial Bank of Commerce restated an "outperform" rating on shares of Nutrien in a research note on Monday, August 10th. BNP Paribas Exane raised shares of Nutrien from a "neutral" rating to an "outperform" rating and set a $80.00 price objective on the stock in a report on Tuesday, July 28th. UBS Group upped their price objective on shares of Nutrien from $59.00 to $62.00 and gave the company a "sell" rating in a report on Tuesday, October 27th. Finally, National Bank Financial cut their price objective on shares of Nutrien from $76.00 to $74.00 and set an "outperform" rating on the stock in a research note on Monday, August 10th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $79.24.

Check Out Our Latest Stock Report on NTR

Nutrien Company Profile

(Get Free Report)

Featured Stories

Earnings History for Nutrien (NYSE:NTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nutrien Right Now?

Before you consider Nutrien, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.

While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines